文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

移植对比慢性输血改善无卒中镰状细胞贫血儿童狭窄结局

Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
PubMed 文献 · Br J Haematol · 2020-11-20

DREPAGREFFE 试验比较造血干细胞移植与标准治疗(慢性输血至少1年)在60例无卒中镰状细胞贫血且经颅多普勒异常儿童中的3年狭窄结局。

要点

  • 移植后无新发狭窄,标准治疗组有2例新发狭窄。
  • 标准治疗组狭窄评分保持稳定,移植组显著改善。

核心结论

  • 在无卒中镰状细胞贫血儿童中,移植较慢性输血可改善3年狭窄结局并预防新发狭窄。

研究设计与样本

  • DREPAGREFFE 试验纳入60例无卒中镰状细胞贫血且经颅多普勒异常的儿童,比较造血干细胞移植与标准治疗(慢性输血至少1年)。

主要发现

  • 移植后无新发狭窄,标准治疗组有2例新发狭窄。

临床怎么用

  • 对有配型同胞供者的无卒中镰状细胞贫血且经颅多普勒异常儿童,可考虑移植以改善狭窄结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report here the 3-year stenosis outcome in 60 stroke-free children with sickle cell anaemia (SCA) and an abnormal transcranial Doppler history, enrolled in the DREPAGREFFE trial, which compared stem cell transplantation (SCT) with standard-care (chronic transfusion for 1-year minimum). Twenty-eight patients with matched sibling donors were transplanted, while 32 remained on standard-care. Stenosis scores were calculated after performing cerebral/cervical 3D time-of-flight magnetic resonance angiography. Fourteen patients had stenosis at enrollment, but only five SCT versus 10 standard-care patients still had stenosis at 3 years. Stenosis scores remained stable on standard-care, but significantly improved after SCT (P = 0·006). No patient developed stenosis after SCT, while two on standard-care did, indicating better stenosis prevention and improved outcome after SCT.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Verlhac S, Gabor F, Paillard C, et al. Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion. Br J Haematol. 2020. PMID: 33216975. doi:10.1111/bjh.17178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。